Literature DB >> 20802263

"Call 911" STEMI protocol to reduce delays in transfer of patients from non primary percutaneous coronary intervention referral Centers.

Terrence Baruch1, Alisa Rock, William J Koenig, Ivan Rokos, William J French.   

Abstract

Primary percutaneous coronary intervention (PPCI) is the preferred method of reperfusion for ST-segment elevation myocardial infarction (STEMI), if it can be performed in a timely manner by an experienced interventional cardiologist at a high volume STEMI Receiving Center. However, an estimated 50% of STEMI patients present to STEMI Referral Centers without PPCI capability. Transfer of STEMI patients for PPCI has been shown to improve outcomes as compared with fibrinolysis given at the presenting hospital. Nonetheless, transfer of STEMI patients for PPCI has not been used extensively in the United States and is associated with markedly prolonged transfer times. This study demonstrates that rapid transfer of STEMI patients from community hospitals without PPCI capability to a STEMI Receiving Center is both safe and feasible using a standardized protocol with an integrated transfer system.

Entities:  

Mesh:

Year:  2010        PMID: 20802263     DOI: 10.1097/HPC.0b013e3181e9d410

Source DB:  PubMed          Journal:  Crit Pathw Cardiol        ISSN: 1535-2811


  2 in total

1.  Timeliness of interfacility transfer for ED patients with ST-elevation myocardial infarction.

Authors:  Michael J Ward; Sunil Kripalani; Alan B Storrow; Dandan Liu; Theodore Speroff; Michael Matheny; Eric J Thomassee; Timothy J Vogus; Daniel Munoz; Carol Scott; Joseph L Fredi; Robert S Dittus
Journal:  Am J Emerg Med       Date:  2015-01-06       Impact factor: 2.469

2.  Regional "Call 911" Emergency Department Protocol to Reduce Interfacility Transfer Delay for Patients With ST-Segment-Elevation Myocardial Infarction.

Authors:  Nichole Bosson; Terrence Baruch; William J French; Andrea Fang; Amy H Kaji; Marianne Gausche-Hill; Alisa Rock; David Shavelle; Joseph L Thomas; James T Niemann
Journal:  J Am Heart Assoc       Date:  2017-12-23       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.